A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
Start Date
10/6/2026
Completion Date
8/1/2030
Summary
The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.
Detailed Description
The Stress Management and Relaxation Response Resiliency Program for lymphoma survivors (SMART3RP-Lymphoma) was adapted by researchers at the MGH. This group program seeks to buffer stress and promote psychological resiliency and physical well-being through a variety of mind-body approaches, such as imagery, relaxation, and yoga, cognitive behavioral strategies, and positive psychology tools. The main questions it aims to answer are: * Will survivors randomized to SMART3RP-Lymphoma demonstrate greater improvements in quality of life when compared to survivors randomized to a Health Education Program? * Will improvements in resiliency lead to improvements in quality of life? To answer these questions, researchers will compare a resilience intervention tailored to the needs of lymphoma survivors (SMART3RP-Lymphoma) to a Health Education Program to see how they affect quality of life of lymphoma survivors. Participants will: * Fill out 4 surveys across 12 months * Participate in 8 weekly, virtual group sessions * Submit hair cortisol samples
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Health Education Program
SMART3RP-Lymphoma
Conditions
Locations
Mass General Hospital
Boston, Massachusetts 02114
United States
Huntsman Cancer Institute
Salt Lake City, Utah 84112
United States